The chemopreventive effects of Protandim: Modulation of p53 mitochondrial translocation and apoptosis during skin carcinogenesis

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Robbins, Delira ^a   Gu, Xin ^b   Shi, Runhua ^a   Liu, Jianfeng ^a   Wang, Fei ^c   Ponville, Jacqulyne ^d   McCord, Joe M ^e   Zhao, Yunfeng ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

^c JILIN UNIVERSITY   (China)

^d NICHOLLS STATE UNIVERSITY   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DIMETHYLBENZ[A]ANTHRACENE; MANGANESE SUPEROXIDE DISMUTASE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTANDIM; PROTEIN BAX; PROTEIN P53; UNCLASSIFIED DRUG; HERBACEOUS AGENT; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER PREVENTION; CELL TRANSFORMATION; CELL TRANSPORT; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; EPIDERMIS CELL; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; SKIN CARCINOGENESIS; WILD TYPE; ANIMAL; CELL LINE; DRUG EFFECT; METABOLISM; SKIN TUMOR; WESTERN BLOTTING;

MURINAE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE; DRUGS, CHINESE HERBAL; MICE; REACTIVE OXYGEN SPECIES; SKIN NEOPLASMS; SUPEROXIDE DISMUTASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77955617571     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011902     Document Type: Article

References (26)

1. Zhao Y, Chaiswing L, Velez JM, Batinic-Haberle I, Colburn NH, et al. (2005) p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase. Cancer Res 65: 3745-3750.
2. Bowden GT, Finch J, Domann F, Krieg P (1995) Molecular mechanisms involved in skin tumor initiation, promotion, and progression. CRC Press, Inc. pp 99-111.
3. Avila GE, Zheng X, Cui XX, Ryan AD, Hansson A, et al. (2005) Inhibitory effects of 12-O-tetradecanoylphorbol-13-acetate alone or in combination with all-trans retinoic acid on the growth of cultured human pancreas cancer cells and pancreas tumor xenographs in immunodeficient mice. J Pharmacol Exp Ther 15: 170-187.
4. Zheng X, Chang RL, Cui XX, Avila GE, Hebbar V, et al. (2006) Effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) in combination with paclitaxel (Taxol) on prostate cancer LnCap cells cultured in vitro or grown as xenongraft tumors in immunodeficient mice. Clin Cancer Res 1: 3444-3451.
5. Zhang X, Li W, Olumi AF (2007) Low dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells. Clin Cancer Res 13: 7181-7190.
6. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B (1997) A model for p53-induced apoptosis. Nature 389: 237-238.
7. Li P-F, Dietz R, von Harsdorf R (1999) p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2. EMBO J 18: 6027-6036.
8. Tang X, Zhu Y, Han L, Kim AL, Kopelovich L, et al. (2007) CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice. J Clin Invest 117: 3753-3764.
9. Liu J, Gu X, Robbins D, Li G, Shi R, et al. (2009) Protandim, a fundamentally new approach in chemoprevention using mouse two-stage skin carcinogenesis as a model. PLoS One 4: e5284. doi:10.1371/journal.pone.0005284.
10. Nelson SK, Bose SK, Grunwald GK, Myhill P, McCord JM (2006) The induction of human superoxide dismutase and catalase in vivo: a fundamentally new approach to antioxidant therapy. Free Radic Biol Med 40: 341-347.
11. Manna SK, Mukhopadhyay A, Van NT, Aggarwal BB (1999) Silymarin suppresses TNF-induced Activation of NF-(kappa) B, cjun N-terminal kinase and apoptosis. J Immunol 163: 6800-6809.
12. Buttke TM, Sandstorm PA (1994) Oxidative stress as a mediator of apoptosis. Immunol Today 15: 7.
13. Hota SK, Barhwal K, Baitharu I, Prasad D, Singh SB, et al. (2009) Bacopa monniera leaf extract ameliorates hypobaric hypoxia induced spatial memory impairment. Neurobiol Dis 34: 23-29.
14. Potapovich AI, Kostyuk VA (2003) Comparative study of antioxidant properties and cytoprotective activity of flavonoids. Biochem (Mosc) 68: 514-519.
15. Chaurasia SS, Panda S, Kar A (2000) Withania somnifera root extract in the regulation of lead-induced oxidative damage in male mouse. Pharmacol Res 6: 663-666.
16. Cheng J, Tang XQ, Zhi JL, Cui Y, Yu HM, et al. (2006) Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion induced apoptosis by bcl-2-mitochondria-ROS-iNos pathway. Apoptosis 11: 943-953.
17. Zhao Y, St Clair DK (2003) Detection of the content and activity of the transcription factor AP-1 in a multistage skin carcinogenesis model. Methods Mol Biol 218: 177-184.
18. Zhao Y, Oberley TD, Chaiswing L, Lin S, Epstein CJ, et al. (2002) Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoterinduced alterations in AP-1 and p53-mediated pathways in a skin cancer model.Oncogene 21: 3836-3846.
19. Vaseva AV, Moll UM (2009) The mitochondrial p53 pathway. Biochimica et Biophysica Acta 1787: 414-420.
20. Katiyar SK, Roy AM, Baliga MS (2005) Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release and caspase activation. Mol Cancer Ther 4: 207-216.
21. Pani G, Koch OR, Galeotti T (2009) The p53-p66shc-manganese superoxide dismutase (MnSOD) network: A mitochondrial intrigue to generate reactive oxygen species. The International J Biochem & Cell Biol 41: 1002-1005.
22. Pani G, Colavitti R, Bedogni B, Fusco S, Ferraro D, et al. (2004) Mitochondrial superoxide dismutase: a promising target for new anticancer therapies. Curr Med Chem 11: 1299-1308.
23. Liu B, Chen Y, Clair DK St (2008) Ros and p53: a versatile partnership. Free Radic Biol Med 44: 1529-1535.
24. Marchenko ND, Zaika A, Moll UM (2005) Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem 280: 19166-19176.
25. Kroemer G, Reed JC (2000) Mitochondrial control of cell death. Nat Med 6: 513-519.
26. Dhar SK, Xu Y, Chen Y, St. Clair DK (2006) Specificity Protein 1-dependent p53-mediated suppression of human manganese superoxide dismutase gene expression. J Biol Chem 281: 21698-21709.